Reply to the comment of Wilbrink et al. on Retrospective analysis of liraglutide and basal insulin combination therapy in Japanese type 2 diabetes: The association between remaining β‐cell function and the achievement of the HbA1c target 1 year after initiation

We have reported that the HbA1c‐lowering effects of liraglutide/basal insulin combination rely on remaining β‐cell function and that the cut‐off value of the C‐peptide immunoreactivity index (CPI), a β‐cell function‐related index frequently used in Japanese clinical settings, is 1.103 for the achiev...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:J Diabetes Investig
Asıl Yazarlar: Usui, Ryota, Sakuramachi, Yui, Seino, Yusuke, Murotani, Kenta, Kuwata, Hitoshi, Tatsuoka, Hisato, Hamamoto, Yoshiyuki, Kurose, Takeshi, Seino, Yutaka, Yabe, Daisuke
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2018
Konular:
Letters to the Editor
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6031522/
https://ncbi.nlm.nih.gov/pubmed/29974670
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/jdi.12858
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller